Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

CLRB holding history

Cellectar Biosciences, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLRB overviewAll 13F holders of CLRBFull Q2 2026 holdings

Shares (Q2 2026)
53,351
Value
$148.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CLRB by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202653,351$148.3K<0.1%+573+1.1%AddedHolders
Q1 202652,778$134.1K<0.1%+24,142+84.3%AddedHolders
Q4 202528,636$84.5K<0.1%+3,744+15.0%AddedHolders
Q3 202524,892$139.4K<0.1%+10,453+72.4%AddedHolders
Q2 202514,439$102.7K<0.1%−428,985−96.7%ReducedHolders
Q1 2025443,424$139.8K<0.1%+92,539+26.4%AddedHolders
Q4 2024350,885$104.9K<0.1%−1,567−0.4%ReducedHolders
Q3 2024352,452$754.4K<0.1%+11,266+3.3%AddedHolders
Q2 2024341,186$853.2K<0.1%+25,102+7.9%AddedHolders
Q1 2024316,084$1.26M<0.1%+247,214+359.0%AddedHolders
Q4 202368,870$190.8K<0.1%+6,022+9.6%AddedHolders
Q3 202362,848$166.0K<0.1%+15,979+34.1%AddedHolders
Q2 202346,869$91.4K<0.1%−374−0.8%ReducedHolders
Q1 202347,243$68.0K<0.1%−784−1.6%ReducedHolders
Q4 202248,027$82.0K<0.1%+3,588+8.1%AddedHolders
Q3 202244,439$149.0K<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q2 2022444,415$179.0K<0.1%+2,532+0.6%AddedHolders
Q1 2022441,883$303.0K<0.1%00.0%UnchangedHolders
Q4 2021441,883$293.0K<0.1%00.0%UnchangedHolders
Q3 2021441,883$408.0K<0.1%+44,713+11.3%AddedHolders
Q2 2021397,170$472.0K<0.1%+152,778+62.5%AddedHolders
Q1 2021244,392$393.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.